Cargando…

Successful Treatment of Early Endometrial Carcinoma by Local Delivery of Levonorgestrel: A Case Report

We describe a case of a 67-year-old Caucasian woman with an early, moderately-differentiated adenocarcinoma of the endometrium. A levonorgestrel-releasing intrauterine system was inserted, which she tolerated well. A full D&C, following removal of the device, was performed after 9 months, confir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wildemeersch, D., Anderson, E., Lambein, K., Pauwels, P., Dhont, M.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2010
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963141/ https://www.ncbi.nlm.nih.gov/pubmed/20981240 http://dx.doi.org/10.1155/2010/431950

Ejemplares similares

Intrauterine levonorgestrel delivery with frameless fibrous delivery system: review of clinical experience
por: Wildemeersch, Dirk, et al.
Publicado: (2017)

Levonorgestrel-IUS system and endometrial manipulation
por: Malik, Sonia
Publicado: (2013)

Femilis(®) 60 Levonorgestrel-Releasing Intrauterine System—A Review of 10 Years of Clinical Experience
por: Wildemeersch, Dirk, et al.
Publicado: (2016)

Characterisation of Levonorgestrel-Resistant Endometrial Cancer Cells
por: Dore, Molly, et al.
Publicado: (2021)

Conservative management of endometrial hyperplasia or carcinoma with the levonorgestrel intrauterine system may be less effective in morbidly obese patients
por: Graul, Ashley, et al.
Publicado: (2018)

Medically unfit women with early-stage endometrial cancer treated with the levonorgestrel intrauterine system
por: Nikolopoulos, Manolis, et al.
Publicado: (2020)

Development of endometrial cancer after long-term usage of the levonorgestrel-releasing intrauterine system
por: Steshenko, Alexander, et al.
Publicado: (2021)

Successful radiotherapy for endometrial serous carcinoma with local repeated recurrence
por: Kusumoto, Shinya, et al.
Publicado: (2018)

Patient experiences of conservative treatment for early stage endometrial cancer and endometrial hyperplasia with atypia using levonorgestrel intrauterine device: A qualitative study
por: O'Hara, Montana, et al.
Publicado: (2021)

Estradiol/levonorgestrel: Pulmonary thromboembolism: case report
Publicado: (2022)

Comparison of Mirena and Liletta levonorgestrel intrauterine devices for the treatment of endometrial intraepithelial neoplasia and grade 1 endometrioid endometrial cancer
por: Chaudhari, Sonal R., et al.
Publicado: (2023)

Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial*
por: Ørbo, A, et al.
Publicado: (2014)

Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel‐impregnated intrauterine system or oral progestogens
por: Ørbo, A, et al.
Publicado: (2015)

The current situation of the levonorgestrel intrauterine system (LNG-IUS) in conservative treatment for patients with early-stage endometrial cancer and atypical hyperplasia
por: Chen, Xiaojun
Publicado: (2019)

The suture fixation of levonorgestrel-releasing intrauterine device in the treatment of adenomyosis: A case report
por: Cui, HaiHong, et al.
Publicado: (2023)

Fertility-Sparing Treatment for Endometrial Cancer: Oncological and Obstetric Outcomes in Combined Therapies with Levonorgestrel Intrauterine Device
por: Pino, Ida, et al.
Publicado: (2022)

Endometrial Cancer Following Levonorgestrel-Releasing Intrauterine System Insertion in Young Women with Atypical Hyperplasia: Two Case Reports and Literature Review
por: Peng, Hongfa, et al.
Publicado: (2022)

Levonorgestrel-releasing intrauterine system-based therapies for early-stage endometrial cancer: a systematic review and meta-analysis
por: Wei, Hongyi, et al.
Publicado: (2023)

Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial protocol
por: Zhao, Xin, et al.
Publicado: (2022)

Weight-Loss Interventions and Levonorgestrel Intrauterine System Implantation for Early-Stage Endometrial Cancer and Atypical Endometrial Hyperplasia to Reduce Perioperative Risk of Severely Obese Patients
por: Isono-Taniguchi, Roze, et al.
Publicado: (2023)

Levonorgestrel-releasing intrauterine system (Mirena) in compare to medroxyprogesterone acetate as a therapy for endometrial hyperplasia
por: Behnamfar, Fariba, et al.
Publicado: (2014)

Correction of Phrase: Medically unfit women with earlystage endometrial cancer treated with the levonorgestrel intrauterine system
por: Nikolopoulos, Manolis, et al.
Publicado: (2020)

Comparison of the effectiveness of the levonorgestrel-intrauterine device and oral progestogens on regression of endometrial hyperplasia without atypia
por: Shen, Ye, et al.
Publicado: (2022)

Dilatation and curettage is more accurate than endometrial aspiration biopsy in early-stage endometrial cancer patients treated with high dose oral progestin and levonorgestrel intrauterine system
por: Kim, Da Hee, et al.
Publicado: (2017)

Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: cost effectiveness analysis
por: Roberts, T E, et al.
Publicado: (2011)

The lost intrauterine levonorgestrel-releasing system in women with adenomyosis: A case report
por: Gunardi, Eka Rusdianto, et al.
Publicado: (2022)

Treatment of menorrhagia due to aplastic anemia by hysteroscopic resection of endometrial functional layer and levonorgestrel-releasing intra-uterine system: Three case reports
por: Yang, Huadi, et al.
Publicado: (2019)

Levonorgestrel-Releasing Intrauterine System and Iron Overload Syndrome
por: Vieira da Motta, Marcia, et al.
Publicado: (2013)

The levonorgestrel intrauterine system versus endometrial ablation for heavy menstrual bleeding: a cost‐effectiveness analysis
por: van den Brink, MJ, et al.
Publicado: (2021)

A Randomized Clinical Trial of Levonorgestrel Intrauterine System with or without Metformin for Treatment of Endometrial Hyperplasia without Atypia in Indian Women
por: Dinnekere Ravi, Ramya, et al.
Publicado: (2021)

Occurrence of anembryonic pregnancy with use of levonorgestrel subdermal implant (JADELLE®): a case report
por: Moutchia-Suh, Jude, et al.
Publicado: (2018)

Levonorgestrel intrauterine system embedded within tubal ectopic pregnancy: a case report
por: Makena, Dorothy, et al.
Publicado: (2021)

Levonorgestrel as a Potential Trigger of Acute Bilateral Central Serous Chorioretinopathy: Case Report
por: Nemet, Vedran
Publicado: (2023)

Provision of the levonorgestrel intrauterine system in Nigeria: Provider perspectives and service delivery costs
por: Brunie, Aurélie, et al.
Publicado: (2020)

Levonorgestrel-Releasing Intrauterine Device-Related Acute Liver Injury
por: Cheema, Hira Imad, et al.
Publicado: (2017)

The role of levonorgestrel intrauterine systems in the treatment of symptomatic fibroids
por: Wrona, Wojciech, et al.
Publicado: (2017)

Segmented in vitro fertilization and frozen embryo transfer in levonorgestrel-releasing intrauterine device treated patients with endometrial cancer
por: Wei, Hongyi, et al.
Publicado: (2023)

A randomized clinical trial to compare levonorgestrel-releasing intrauterine system (Mirena) vs trans-cervical endometrial resection for treatment of menorrhagia
por: Ghazizadeh, Shirin, et al.
Publicado: (2011)

Cornual pregnancy as a complicaton of the use of a levonorgestrel intrauterine device: a case report
por: Beltman, JJ, et al.
Publicado: (2009)

Rational Design of a Multipurpose Bioadhesive Vaginal Film for Co-Delivery of Dapivirine and Levonorgestrel
por: Li, Jing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nqfd27dntjk3m47hi3bov148ig